<code id='8A224E13DD'></code><style id='8A224E13DD'></style>
    • <acronym id='8A224E13DD'></acronym>
      <center id='8A224E13DD'><center id='8A224E13DD'><tfoot id='8A224E13DD'></tfoot></center><abbr id='8A224E13DD'><dir id='8A224E13DD'><tfoot id='8A224E13DD'></tfoot><noframes id='8A224E13DD'>

    • <optgroup id='8A224E13DD'><strike id='8A224E13DD'><sup id='8A224E13DD'></sup></strike><code id='8A224E13DD'></code></optgroup>
        1. <b id='8A224E13DD'><label id='8A224E13DD'><select id='8A224E13DD'><dt id='8A224E13DD'><span id='8A224E13DD'></span></dt></select></label></b><u id='8A224E13DD'></u>
          <i id='8A224E13DD'><strike id='8A224E13DD'><tt id='8A224E13DD'><pre id='8A224E13DD'></pre></tt></strike></i>

          Home / explore / leisure time

          leisure time


          leisure time

          author:Wikipedia    Page View:41
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In